RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Design, synthesis, and biological evaluation of structurally rigid analogues of 4-(3-Hydroxyphenyl)piperidine opioid receptor antagonists
Runyon, S. P., Kormos, C. M., Gichinga, M. G., Mascarella, S. W., Navarro, H. A., Deschamps, J. R., Imler, G. H., & Carroll, F. I. (2016). Design, synthesis, and biological evaluation of structurally rigid analogues of 4-(3-Hydroxyphenyl)piperidine opioid receptor antagonists. Journal of Organic Chemistry, 81(21), 10383-10391. https://doi.org/10.1021/acs.joc.6b01366
In order to gain additional information concerning the active conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine (1) class of opioid receptor antagonists, procedures were developed for the synthesis of structurally rigid N-substituted-6-(3-hydroxy-phenyl)3-azabicyclo[3.1.0]hexane and 3-methyl-4-(3-hydroxyphenyl)-4-azabicyclo[4.1.0]heptanes. Evaluation of the conformationally constrained series in a [S-35]GTP gamma S assay showed that structural rigid compounds having the 3-hydroxyphenyl group locked in the piperidine equatorial orientation had potencies equal to or better than similar compounds having more flexible structures similar to 1. The studies of the rigid compounds also suggested that the 3-methyl group present in compound 1 type antagonists may not be necessary for their pure opioid antagonist properties.
